Status:
WITHDRAWN
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Conditions:
Pandemic Influenza
Eligibility:
All Genders
Brief Summary
This aim of this project is to evaluate the efficacy of neuraminidase inhibitors as prophylaxis against pandemic influenza infection in patients who are prescribed a long term course in the context of...
Detailed Description
The aim of this study is to 1. Describe the incidence of symptomatic pandemic influenza infection in participants receiving neuraminidase inhibitor prophylaxis in the context of a place of employment...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Intention to commence, or already commenced prophylaxis with a neuraminidase inhibitor in the context of a place of employment or profession
- It is anticipated that participants in this study who are subsequently clinically diagnosed with pandemic influenza will be enrolled in the Index Case protocol (PIPET-A) with follow-up as specified.
Exclusion
- none
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640211
Last Update
April 24 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
St Vincent's Hospital
Sydney, New South Wales, Australia, 2010
2
Prince of Wales Hospital
Sydney, New South Wales, Australia, 2031
3
Westmead Hospital
Sydney, New South Wales, Australia, 2145
4
Royal Brisbane Hospital
Brisbane, Queensland, Australia, 4000